The earnings call reflected a generally positive outlook with strong revenue growth and strategic execution, particularly in high potential accounts and clinical training. However, there are concerns about gross margin pressure and uncertainties regarding the logistics post-BLA approval.

Company Guidance -

Q3 2025

During the call, Axogen provided comprehensive financial guidance for the remainder of fiscal year 2025. The company reported second-quarter sales of $56.7 million, marking an 18.3% increase compared to the same period last year, driven by a 3% rise in price and a 15% increase in unit volume and mix. Gross profit for the quarter reached $42 million, with a gross margin of 74.2%, up from 73.8% the previous year. Operating expenses increased to $40.3 million, but as a percentage of revenue, they decreased by 3.5%. The company achieved a net income of $0.6 million or $0.01 per share, a significant improvement from a net loss of $1.9 million in the second quarter of 2024. Axogen raised its full-year revenue growth guidance to at least 17%, equating to revenue of at least $219 million, and maintained its gross margin guidance in the range of 73% to 75%. The company also expects to be net cash flow positive for the year and to self-fund its strategic plan with growing cash from operations.

Strong Revenue Growth

Q2 sales increased to $56.7 million, growing 18.3% compared to the same period last year, driven by double-digit growth across all nerve repair target markets.

High Potential Accounts Productivity

Approximately 70% of revenue growth driven by high potential accounts, with average high potential account productivity up 21% year-over-year.

Surgeon Training Progress

Surgeon training programs are on track, with significant increases in trained surgeons year-to-date across various applications.

Clinical and Market Development

Completion of hiring of the clinical development team and progress in prostate clinical and market development plan, with 6 active pilot sites.

Financial Performance

Net income for the quarter was $0.6 million compared to a net loss of $1.9 million in the second quarter of 2024. Adjusted EBITDA for the quarter was $9.3 million compared to $5.6 million in the same period last year.

AxoGen (AXGN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

AXGN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2025 (Q3)	0.07 / -	0.07	―	―	―
Aug 05, 2025	2025 (Q2)	0.06 / 0.12	0.05	140.00% (+0.07)
May 08, 2025	2025 (Q1)	0.01 / -0.02	-0.06	66.67% (+0.04)	―
Feb 25, 2025	2024 (Q4)	0.04 / 0.07	-0.06	216.67% (+0.13)
Nov 07, 2024	2024 (Q3)	<0.01 / 0.07	0.01	600.00% (+0.06)
Aug 08, 2024	2024 (Q2)	-0.06 / 0.05	-0.03	266.67% (+0.08)
May 02, 2024	2024 (Q1)	-0.07 / -0.06	-0.1	40.00% (+0.04)	―
Mar 05, 2024	2023 (Q4)	-0.07 / -0.06	-0.03	-100.00% (-0.03)	―
Nov 07, 2023	2023 (Q3)	-0.06 / 0.01	-0.01	200.00% (+0.02)
Aug 07, 2023	2023 (Q2)	-0.12 / -0.03	-0.06	50.00% (+0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

AXGN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$12.55	$13.72	+9.32%
May 08, 2025	$16.39	$12.59	-23.18%
Feb 25, 2025	$18.01	$20.11	+11.66%
Nov 07, 2024	$15.33	$13.27	-13.44%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does AxoGen (AXGN) report earnings?

AxoGen (AXGN) is schdueled to report earning on Nov 11, 2025, After Close (Confirmed).

What is AxoGen (AXGN) earnings time?

AxoGen (AXGN) earnings time is at Nov 11, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is AXGN EPS forecast?

AXGN EPS forecast for the fiscal quarter 2025 (Q3) is 0.07.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing